top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_980,h_718,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search
HeartLung.AI Showcases Breakthrough AI-CVD™ and AI-CAC™ Technologies at SCCT 2025 in Montreal
HOUSTON, TX, UNITED STATES, July 8, 2025 / EINPresswire.com / -- HeartLung.AI , a leader in AI-powered medical imaging solutions for...
Capitol Imaging Services Partners with HeartLung Technologies to offer Artificial Intelligence-Enabled Opportunistic Screening for Osteoporosis and Heart Disease
HeartLung Technologies partners with Capitol Imaging Services to offer Artificial Intelligence-Enabled Osteoporosis Screening (AutoBMD™ AI and AutoChamber™ AI) as an add-on to CT Scans in Alabama.
Celebrating the Multifaceted Talents of HeartLung's Distinguished Advisor, World-renowned Cardiologist, Dr. Robert A. Kloner: New Album Release "Fillmore Station"
Dr. Robert A. Kloner's latest musical endeavor, "Fillmore Station," is a blend of piano-based neo-classical and new age music.
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality:
Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality
HeartLung Technologies Secures CMS Reimbursement for AutoChamber™ with New HCPCS Code
CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.
HeartLung Technologies Presented 3 Groundbreaking AI Studies at BMEII 2025 New York Academy of Medicine
HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.
HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Osteoporosis Screening (AutoBMD™ AI) as an add-on to CT Scans Nationwide
SimonMed Imaging partners with HeartLung.AI to roll out AutoBMD™ AI for osteoporosis screening, enhancing preventive healthcare.
Harmonizing Healthcare and Innovation: HeartLung Technologies Welcomes Dr. Robert A. Kloner to the Advisory Board
HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.
HeartLung’s 2024 Year in Review - Milestones and Pipeline for 2025
2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!
HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️
HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024!
HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)
HeartLung is the only AI company participating in RSNA 2024 as a scientific presenter of research studies and as an industry exhibitor
HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024
Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...
HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™
The First AI that Enables Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans SUMMARY: HeartLung Technologies (...
Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London
Pioneering research by Dr. Naghavi's team from American Heart Technologies and HeartLung.AI highlights AI's transformative impact on...
HeartLung's AI-Enabled AutoChamber™ Selected as SCCT 2023 Best Abstract Award Finalist 🏆⚕️
HeartLung's AI-Enabled AutoChamber™ Selected as SCCT 2023 Best Abstract Award Finalist
bottom of page